… protected the heart from cardiac hypertrophy in vivo, we next … AngII-induced activation of
hallmarks of the MAPK and AKT/… -induced hypertrophy, we need to overexpress the full-length or …

… ; stiffens the heart and impairs cardiac contraction) and inadequate … (nuclear-targeted Akt)
had normal heart size and function … has not been reported in vivo. However, delivery of human …

… that Akt activation was required for VEGF-induced angiogenic … , reducing myocardial ischaemic
injury in vivo, whereas CM-… Regulation of myocardial contractility and cell size by distinct …

… , characterized by increased cell size and activation of … expression in vivo to show that
restoration of AKT function … AAV-AKT administration may increase cardiac contractility or …

… for Akt in cardiac homeostasis. To this end, this study was designed to examine the role of
Akt2 in acute paraquat exposure-induced cardiac contractile and … changes in cell length during …

… by wogonin in isoprenaline-induced myocardial hypertrophy in vivo and in vitro. It …
enhancement in hypertrophic development, including amplification of cell size and activation of Akt …

… volume stress and many other problems. Initially, it is adaptively against increased workload
or defects in the efficiency of contractile … and in vivo, however, chronic Akt overexpression is …

… tissues, by which DM-induced cardiac dysfunction and … , and the myocardial cells were
well-arranged, the size was … the surface area of myocardial cells significantly increased in the DM, …

… Besides, PI3Kα may regulate cardiac fibrosis via affecting the myocardial contractility since
… or rapamycin in vivo. However, the Akt inhibitors possess the ability to induce an increase in …

… with longer duration of effect in vivo have been explored, among … dimension (LVID) and
significant decrease in contractility … We measured the heart weight/tibia length and heart weight/…